Virax Biolabs Group Stock Forecast

Buy or Hold candidate since May 21, 2026 Loss -38.50%

The Virax Biolabs Group Limited stock price fell by -9.87% on the last day (Tuesday, 9th Jun 2026) from $0.209 to $0.188. During the last trading day the stock fluctuated 13.02% from a day low at $0.174 to a day high of $0.197. The price has fallen in 7 of the last 10 days and is down by -17.09% for this period. Volume has increased on the last day by 447 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $231.60 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.90% during the next 3 months and, with a 90% probability hold a price between $0.148 and $0.373 at the end of this 3-month period.

VRAX Signals & Forecast

A sell signal was issued from a pivot top point on Wednesday, May 20, 2026, and so far it has fallen -41.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Virax Biolabs Group Limited gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". Some positive signals were issued as well, and these may have some influence on the near short-term development. The Virax Biolabs Group Limited stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.206. On a fall, the stock will find some support from the long-term average at approximately $0.183. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.

Support, Risk & Stop-loss for Virax Biolabs Group Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.166 and $0.150. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Virax Biolabs Group Limited finds support just below today's level at $0.166. If this is broken, then the next support from accumulated volume will be at $0.150 and $0.148.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0227 between high and low, or 13.02%. For the last week, the stock has had daily average volatility of 16.34%.

Our recommended stop-loss: $0.178 (-5.42%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (VRAX) For The Upcoming Trading Day Of Wednesday 10th

For the upcoming trading day on Wednesday, 10th we expect Virax Biolabs Group Limited to open at $0.187, and during the day (based on 14 day Average True Range), to move between $0.164 and $0.212, which gives a possible trading interval of +/-$0.0483 (+/-29.43%) up or down from last closing price. If Virax Biolabs Group Limited takes out the full calculated possible swing range there will be an estimated 29.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.166 (11.58%) than the resistance at $0.220 (16.84%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Virax Biolabs Group Limited stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

Current score: 1.504 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 10, 2026 - $0.187 ( 0.90%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk